• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BXN
Click for more information
16.7% 1.5¢

BIOXYNE LIMITED

Market Cap $26.60M  ! watchlist Created with Sketch. Add to my watchlist

Bioxyne Limited is an Australia-based international consumer health and pharmaceutical... Bioxyne Limited is an Australia-based international consumer health and pharmaceutical company. The Company is focused on health and wellness products, psychotropic and investigational medicines. The Company operates through three segments: Wholesale PCC/USA, Consumer Health Products UK/ EU/JPN, and Pharmaceuticals AUS. Its subsidiary, Breathe Life Sciences (BLS) manufactures, commercializes, and distributes plant-based wellness products and supplements, including cannabidiol (CBD), cannabis extracts, vitamins, manuka honey, skin care products and mushroom complexes. BLS operates in Australia, the United Kingdom, Japan, and Europe with four accredited manufacturing facilities across four countries Japan, Australia, the United Kingdom, and Czechia. The Company direct sales arm and has developed a range of functional food products containing ingredients sourced exclusively from New Zealand and sold in Asia.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
BXN
Ann: Appendix 4D and Half Year Accounts 		25/03/19 14 2.0K
25/03/19 Last post  zerodark30 Comments Created with Sketch.  14  Views Created with Sketch.  2.0K 
BXN
Asia loves milk+BXN has milk & making a tonne of $ 		22/02/19 0 464
22/02/19 Last post  zx65 Comments Created with Sketch.  0  Views Created with Sketch.  464 
BXN
Ann: Appendix 4C - quarterly 		31/01/19 1 691
31/01/19 Last post  zerodark30 Comments Created with Sketch.  1  Views Created with Sketch.  691 
BXN
Ann: Final Director's Interest Notice 		21/01/19 0 251
21/01/19 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  251 
BXN
Ann: Director Resignation 		18/01/19 1 754
18/01/19 Last post  vbdankhra Comments Created with Sketch.  1  Views Created with Sketch.  754 
BXN
Malaysia launch Mymana NZ milk, colostrum & honey 		13/01/19 6 2.3K
13/01/19 Last post  zerodark30 Comments Created with Sketch.  6  Views Created with Sketch.  2.3K 
BXN
Ann: Change of Directors Interest Notice X 5 		21/12/18 0 259
21/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  259 
BXN
Ann: Appendix 3B 		21/12/18 0 160
21/12/18 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  160 

See All Discussions arrow Created with Sketch.
(20min delay)
Last
1.5¢ 		Change
-0.003(16.7%) 		Mkt cap ! $26.60M
Open High Low Value Volume
1.9¢ 2.1¢ 1.5¢ $85.90K 4.888M

Buyers (Bids)

No. Vol. Price($)
7 1400075 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 67981 1
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
Last
1.6¢ 		  Change
-0.003 ( 11.1 %)
Open High Low Volume
2.0¢ 2.1¢ 1.5¢ 3408417
Last updated 15.57pm 29/11/2024 ?
BXN (ASX) Chart

Top Stories

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Good afternoon, a happy end of the week, and welcome to HotCopper Highlights – I’m Jonathon Davidson. Let’s get into it.
Parkes Au-Cu project to 'transform' Adavale Resources with key targets Adavale Resources Ltd has entered into an all-scrip acquisition of the Parkes gold and copper project in New South Wales
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor The ASX200 has been really flirting with the 8,500pts mark this week, notching an intraweek ATH of 8,476pts.
Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher Vitrafy Life Sciences Limited (ASX:VFY) has defied this month’s odds to become the only newly-listed Australian company to survive a surprisingly rough November (for newcomers, at least) without sagging below its IPO price.The cryopreservation biotech did give some back on Friday,...
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.